Report overview
Sterile Water for Injection (SWFI) is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use.
SWFI are used for reconstitution of lyophilized drugs, diluent of injection solution and rinsing agent for endoscopy in various departments. SWFI for reconstitution of lyophilized drugs.
In this report, we only collect data of SWFI being sold as a part of set with LYO drug.
This report aims to provide a comprehensive presentation of the global market for SWFI for Reconstitution of Lyophilized Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding SWFI for Reconstitution of Lyophilized Drugs. This report contains market size and forecasts of SWFI for Reconstitution of Lyophilized Drugs in global, including the following market information:
Global SWFI for Reconstitution of Lyophilized Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global SWFI for Reconstitution of Lyophilized Drugs Market Sales, 2018-2023, 2024-2029, (Ton)
Global top five SWFI for Reconstitution of Lyophilized Drugs companies in 2022 (%)
The global SWFI for Reconstitution of Lyophilized Drugs market was valued at US$ 13 million in 2022 and is projected to reach US$ 17 million by 2029, at a CAGR of 3.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Asia-Pacific and Europe are the two largest consumption regions, with a consumption market share nearly 40% and 30%. North America is also an important sales region.
Market competition is intense. Baxter, Hospira (ICU Medical), Vetter, Otsuka, ROVI, Fresenius Kabi, etc. are the leaders of the industry, they hold key technologies and patents, with high-end customers.
The classification of SWFI for reconstitution of lyophilized drugs includes Vials and Ampoules and Pre-Filled Syringes. The sales proportion of Vials and Ampoules is over 95%.
SWFI for reconstitution of lyophilized drugs is widely used for vaccines, Biological Products, Bio-pharmaceutical. The most proportion of SWFI for reconstitution of lyophilized drugs is used for vaccine, the proportion is about 73%.
We surveyed the SWFI for Reconstitution of Lyophilized Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global SWFI for Reconstitution of Lyophilized Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, by Type, 2022 (%)
Vials
Pre-filled Syringes
Global SWFI for Reconstitution of Lyophilized Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global SWFI for Reconstitution of Lyophilized Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Ton)
Global SWFI for Reconstitution of Lyophilized Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies SWFI for Reconstitution of Lyophilized Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies SWFI for Reconstitution of Lyophilized Drugs revenues share in global market, 2022 (%)
Key companies SWFI for Reconstitution of Lyophilized Drugs sales in global market, 2018-2023 (Estimated), (Ton)
Key companies SWFI for Reconstitution of Lyophilized Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer(Hospira)
B. Braun Medical Inc.
Baxter Corporation
Hikma
Fresenius Kabi
China Otsuka
Kelun
Shijiazhuang No. 4 Pharmaceutical
Deo Gratias Parenteral
Shapuaisi Pharma
Zhuhai Tongyuan Pharmaceutical
Shandong Qidu Pharma Group
Huaren
Outline of Major Chapters:
Chapter 1: Introduces the definition of SWFI for Reconstitution of Lyophilized Drugs, market overview.
Chapter 2: Global SWFI for Reconstitution of Lyophilized Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of SWFI for Reconstitution of Lyophilized Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of SWFI for Reconstitution of Lyophilized Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global SWFI for Reconstitution of Lyophilized Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.